1 / 8

Cancer Therapeutics Market Expected to Reach $178,863 Million, Globally, by 2023

The Global Cancer Therapeutics Market was valued at $81,291 million in 2016 and is estimated to reach at $178,863 million by 2023, registering a CAGR of 11.9% from 2017 to 2023. Cancer therapeutics involves the use and administration of chemotherapy and oncology drugs to treat cancer.<br>

srushtih123
Download Presentation

Cancer Therapeutics Market Expected to Reach $178,863 Million, Globally, by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Cancer Therapeutics Market by Key Players, Product, Analysis and Forecast Global Opportunity Analysis and Industry Forecast, 2017-2023

  2. Cancer Therapeutics Market “Prevalence of cancer is on the rise throughout the world. Advanced therapeutics are being developed by pharmaceutical companies to address the growing burden of cancer. The time and costs associated with oncology drug development are also increasing; hence the key companies are collaborating with other pharmaceutical companies to reduce these costs.”

  3. Cancer Therapeutics Market Overview Cancer Therapeutics Market by Application and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the market was valued at $81,291 million in 2016, and is projected to reach $178,863 million by 2023, at a CAGR of 11.9% from 2017-2023. The market is driven by factors such as development of novel cancer therapeutics and surge in cancer awareness & availability of oncology drugs in developing markets. Access Full Summary at : https://www.alliedmarketresearch.com/cancer-therapeutics-biotherapeutic-market The key drivers of the global cancer therapeutics market are surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics; furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. 

  4. Cancer Therapeutics Market The cancer therapeutics market is segmented based on application, top selling drugs, and region. Based on application, the market is divided into blood cancer, lung cancer, colorectal cancer, prostate cancer, breast cancer, cervical cancer, and others. By top selling drugs, it is categorized into Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.  The lung cancer segment dominated the cancer therapeutics market, owing to the surge in prevalence of lung cancer and favorable government regulations towards lung cancer therapeutics.

  5. Cancer Therapeutics Market, Snapshot A rise in focus of vendors on the emerging markets, such as Asia-Pacific and LAMEA is expected to boost the market growth. Asia-Pacific is projected to witness significant growth in future, owing to increase in R&D investment and surge in cancer awareness. Furthermore, this region presents remarkable opportunities for the venture capitalists and investors, as the developed markets are comparatively saturated. The report provides an extensive competitive analysis and profiles of the key market players such as F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie, Inc., Johnson & Johnson, Celgene Corporation, Astellas Pharma, Inc., Pfizer, Inc., Novartis AG, Merck KGaA, and Eli Lilly and Company. The other players in the value chain (not included in the report) include AstraZeneca plc, Bayer AG, and Takeda Pharmaceutical Company Limited. 

  6. Key Benefits of Cancer Therapeutics Market • This report entails a detailed quantitative analysis of the market trends from 2016 to 2023 to identify the prevailing opportunities along with strategic assessment of the global cancer therapeutics market. • Cancer therapeutics market size and market estimations are based on a comprehensive analysis of the applications, top selling drugs, and developments in the industry. • An in-depth analysis based on region assists to understand the regional market and facilitate the strategic business planning. • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market. 

  7. Cancer Therapeutics Market North America Europe Asia-Pacific LAMEA

  8. Cancer Therapeutics Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/480 Follow Us On

More Related